TEM slips nearly 7% as stock remains below major moving averages despite new contracts
Tempus AI (TEM) dropped 6.73% after quarterly results, with selling pressure deepening despite robust growth in revenue and strategic new contracts. The down move is reinforced by the stock’s position below all major moving averages and technical signals showing persistent downside momentum.
Highlights
- Tempus AI reported $411.5 million in third-quarter 2026 revenue, up 23% year over year with increased oncology and data segment performance.
- The company renewed a multi-year $200 million master agreement with AstraZeneca and entered a $55 million collaboration with Pathos, supporting future revenue.
- Shares of Tempus AI trade below key moving averages with persistent downside momentum and an expected five-day range of $50.19 to $60.6.
Future revenue support as new contracts and insider sales alter sentiment
Tempus AI reported third-quarter 2026 revenue of $411.5 million, reflecting a 23% year-over-year increase, alongside strong growth in oncology units and its Data & Applications segment. The company renewed its master services agreement with AstraZeneca, securing a $200 million multi-year commitment, and entered a $55 million collaboration with Pathos, both expected to support future revenue. Key executives sold shares to cover tax obligations associated with vesting restricted stock units. An agreement to acquire Personalis, a cancer-testing company, is pending shareholder approval and expected to close in the fourth quarter of 2026, though price action has remained under broader selling pressure.
Persisting bearish momentum as price stalls below technical barriers
Tempus AI is trading below its 20-day, 50-day, and 200-day moving averages, with the current price at $55.6 compared to $72.78 (MA-20), $72.89 (MA-50), and $57.57 (MA-200). This alignment signals persistent selling pressure across short, medium, and long-term trends. The 200-day moving average at $57.57 acts as a near-term ceiling, while today’s low at $55.05 serves as immediate support. Momentum readings remain bearish, with the MACD and ADX indicating downside momentum and a lack of trend strength. The RSI is neutral and does not show signs of exhaustion, but both the Stochastic RSI and CCI are in oversold zones, suggesting some short-term selling exhaustion risks. Bear Power remains negative, intraday sellers dominate, and the Awesome Oscillator confirms prevailing negative momentum. The stock is down $4.01 or 6.73% on the session, following a sizeable downside gap of about $1.62 (2.72%), with the price pinned near the low. Intraday volatility measures 5.99%.
Earlier, analysts noted that Tempus AI's robust revenue growth and expanded commercial partnerships established a broadly bullish technical outlook despite short-term price weakness. The current breakdown below major moving averages and persistent downside momentum signals a shift to a more cautious stance, making the $55.05 support a pivotal level to watch for signs of stabilization or further declines.